Plasma homocysteine in early and late pregnancies complicated with preeclampsia and isolated intrauterine growth restriction

References

• Roberts JM. Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol 1998; 16: 5–15.
   PubMedGoogle Scholar
• Graham IM, Daly LE, Refsum HM, Robinson K, Brattstorm LE et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 1997; 277: 1775–81.
   Google Scholar
• Stampfer MJ, Malinow MR, Willet WC, Newcomer LM, Upson B et al. A prospective study of plasma homocysteine and risk of myocardial infarction in US Phisicyans. JAMA 1992; 268: 877–81.
   PubMed Web of Science ®Google Scholar
• Blundell G, Jones BG, Rose PA, Tundball N. Homocysteine mediated endothelial cell toxicity and its amelioration. Atherosclerosis 1996; 122: 163–72.
   PubMed Web of Science ®Google Scholar
• Wang J, Dudman NP. Wilcken DE. Effects of homocysteine and related compounds on prostacyclin production by culturedhuman vascular endothelial cells. Thromb Haemost 1993; 70: 1047–52.
   Google Scholar
• Freyburger G, Labrouche S, Sassoust G, Rouanet F, Javorschi S, Parrot F. Mild hyperomocystinemia and hemostatic factor in patients with arterial vascular diseases. Thromb Haemost 1997; 77: 466–71.
   PubMedGoogle Scholar
• Dekker JA, de Vries JI, Doelitzsch PM, Huijgens PC, von Blomberg BM, Jacobs C et al. Underlying disorders associated with severe early-onset preeclampsia. Am J Obstet Gyencol 1995; 173: 1042–8.
   PubMed Web of Science ®Google Scholar
• Rajkovic A, Catalano PM, Malinow MR. Elevated homocysteine levels with preeclampsia. Obstet Gynecol 1997; 90: 168–71.
   Google Scholar
• Powers RW, Evans RW, Majors AK, Ojimba JI, Ness RB, Crombleholme WR et al. Plasma homocysteine is increased in preeclampsia and is associated with evidence of endothelial activation. Am J Obstet Gynecol 1998; 179: 1605–11.
   Google Scholar
• Powers RW, Evans RW, Ness RB, Crombleholme WR, Roberts JM. Homocysteine and cellular fibronectin are increased in preeclampsia, not in transient hypertension of pregnancy. Hyper Pregn 2001; 20: 69–77.
   Google Scholar
• de Vries JI, Dekker JA, Huijgens PC, Jakobs C, Blomberg BM, Van Geijn HP. Hyperhomocysteinaemia and protein S deficiency in complicated pregnancies. Br J Obstet Gynaecol 1997; 104: 1248–54.
   Google Scholar
• Vollset SE, Refsum H, Irgens LM, Emblem BM, Tverdal A, Gjessing MonsenAL et al. Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordal and Homocysteine study. Am J Clinnutr 2000; 71: 962–8.
   PubMed Web of Science ®Google Scholar
• Sorensen TK, Malinow MR, Williams MA, King IB, Cuthy DA. Elevated second trimester serum homocysteine levels and subsequent risk of preeclampsia. Gynecol Obstet Invest 1999; 48: 98–103.
   Google Scholar
• Cotter AM, Molloy AM, Scott JM, Daly SF. Elevated plasma homocysteine in early pregnancy. A risk factor for the development of severe preeclampsia. Am J Obstet Gynecol 2001; 185: 781–5.
   PubMedGoogle Scholar
• Gairdner D, Pearson J. A growth chart for premature and other infants. Arch Dis Child 1971; 46: 783–7.
   PubMed Web of Science ®Google Scholar
• Hietala R, Turpeinen U, Laatikainen T. Serum homocysteine at 16 weeks and subsequent preeclampsia. Obstet Gynecol 2001; 97: 527–9.
   Google Scholar
• Hogg BB, Tamura T, Johnston KE, Dubard MP, Goldenberg RL. Second-trimester plasma homocysteine levels and pregnancy-induced hypertension, preeclampsia, and intrauterine growth restriction. Am J Obstet Gynecol 2000; 183: 805–9.
   Google Scholar
• Leeda M, Riyazi N, de Vries JI, Jakobs C, van Geijn HP, Dekker JA. Effects of folic acid and vitamin B6 supplementation on women with hyperhomocystinemia and a history of preeclampsia or fetal growth restriction. Am J Obstet Gynecol 1998; 179: 135–9.
   PubMed Web of Science ®Google Scholar
• Burke G, Robinson K, Refsum H, Drumm J, Graham IM. Intrauterine growth retardation, perinatal death, and maternal homocysteine levels. New Engl J Med 1992; 326: 69–70.
   Google Scholar
• Laivuori H, Kaaja R, Turpeinen U, Viinikka L, Ylikorkala O. Plasma homocysteine levels elevated and inversely related to insulin sensitivity in preeclampsia. Obstet Gynecol 1999; 93: 489–93.
   Google Scholar
• Raijmakers MTM, Zusterzeel PLM, Steegers EAP, Hectors MPC, Demacker PNM, Peters WHM. Plasma thiol status in preeclampsia. Obstet Gynecol 2000; 95: 180–4.
   PubMed Web of Science ®Google Scholar
• Aubard Y, Darodes N, Cantaloube M. Hyperhomocystinemia and pregnancy – review of our present understanding and therapeutic implications. Eur J Obstet Gynecol Reprod Biol 2000; 93: 157–65.
   Google Scholar
• Walker MC, Smith GN, Perkins SL, Keely EJ, Garner PR. Changes in homocysteine levels during normal pregnancy. Am J Obstet Gynecol 1999; 180: 660–4.
   PubMed Web of Science ®Google Scholar
• Malinow MR, Rajkovic A, Duell PB, Hess DL, Upson BM. The relationship between maternal and neonatal umbilical cord plasma homocysteine suggest a potential role for maternal homocysteine in fetal metabolism. Obstet Gynecol 1998; 178: 228–33.
   Google Scholar
• Raijmakers MYM, Zusterzeel PLM, Steegers EAP, Peters WHM. Hyperhomocystinemia: a risk factor for preeclampsia? Eur J Obstet Gynecol Reprod Biol 2001; 95: 226–8.
   PubMed Web of Science ®Google Scholar